Omega Healthcare Investors(OHI) - 2025 Q1 - Earnings Call Transcript

Financial Data and Key Metrics Changes - Adjusted funds from operations (AFFO) for Q1 2025 were $0.75 per share, and funds available for distribution (FAD) were$0.71 per share, reflecting revenue and EBITDA growth, with leverage reduced to 3.7x debt to EBITDA [5][12] - Revenue for Q1 2025 was $277 million, up from$243 million in Q1 2024, primarily due to new investments and operator restructurings [9] - Net income for Q1 2025 was $112 million or$0.33 per share, compared to $69 million or$0.27 per share in Q1 2024 [10] Business Line Data and Key Metrics Changes - The percentage of private pay and other revenue increased from 8% ten years ago to 39% today, with expectations for continued growth in this area [8] - Maplewood paid $15.6 million in rent in Q1 2025, an increase of$3.3 million from Q4 2024, and occupancy for the Maplewood portfolio reached 94% as of April 2025 [20] Market Data and Key Metrics Changes - The UK market accounted for approximately 93% of total new investments in Q1 2025, with a strong pipeline of opportunities [23][25] - The trailing twelve-month operator EBITDAR coverage for the core portfolio increased to 1.51x as of December 31, 2024, indicating improved performance [18] Company Strategy and Development Direction - The company is focused on disciplined and sustainable investment decisions while expanding its operator base in both the US and UK markets [18][24] - Omega is looking to opportunistically fund investments with equity, positioning itself for outsized adjusted FFO growth [13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability of Genesis to continue paying rent despite recent liquidity issues, citing strong coverage metrics [6][33] - The company remains optimistic about the overall coverage and fundamentals improving in the healthcare sector, despite potential Medicaid cuts [28][29] Other Important Information - The company raised and narrowed its full-year adjusted FFO guidance to a range between $2.95 to$3.01 per share [14] - The company has a strong balance sheet with $368 million in cash and full borrowing capacity of its$1.45 billion credit facility [12] Q&A Session Summary Question: Details on Genesis and its rent payment issues - Management indicated that Genesis's recent rent payment issues were a one-time event related to their ABL lender tightening availability, and they expect continued payments moving forward [31][33] Question: Insights on the UK portfolio acquisition - The UK acquisition was facilitated by a strong platform and relationships with multiple operators, allowing for a quick and efficient transaction [39][41] Question: Impact of immigration on labor availability - No significant impact on labor availability or wage pressures has been observed at this time [45] Question: Genesis's operating fundamentals - Coverage metrics for Genesis have improved, with the portfolio consistently above 1.5 times [47] Question: Provider tax and Medicaid changes - The greatest risk to traditional Medicaid is provider taxes, which may see slight reductions, but the overall impact remains uncertain [76][78] Question: Disposition strategy and market opportunities - The company executed dispositions to redeploy capital effectively, taking advantage of attractive offers for non-core assets [82][84]